Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000228330 is classified as a pseudogene similar to part of COX10 homolog (cytochrome c oxidase assembly protein, heme A: farnesyltransferase)[7]. Pseudogenes are non-coding genetic elements that resemble functional genes but have lost their ability to code for active proteins due to evolutionary DNA sequence changes[5][9]. This particular pseudogene is related to COX10, a nuclear gene encoding an enzyme essential for mitochondrial heme A biosynthesis, a key process in cytochrome c oxidase (Complex IV) assembly and function[1]. Pseudogenes such as ENSG00000228330 typically do not contribute to protein function, are not considered drug targets, and do not directly participate in disease mechanisms, although their existence may inform genomic structural studies[5][7].\n\nKey clarifications:\n- It is not a therapeutic target.\n- Its entry as a “target” is incorrect based on standard pharmacological and biochemical definitions.\n- There is no known biological function, disease association, or drug interaction specific to this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of COX10 homolog, cytochrome c oxidase assembly protein, heme A: farnesyltransferase.